Blog

Progress updates on Lynch syndrome vaccines at CAP-IT Meeting – CAP-IT

Photo taken from www.gavi.org

Sep 21, 2024, 15:30

Progress updates on Lynch syndrome vaccines at CAP-IT Meeting – CAP-IT

NCI’s Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Network posted the following on X:

“At today’s CAPITSC Meeting, Drs. Shizuko Sei (NCI), Alan Hutson (Roswell Park), and Margie Clapper (Fox Chase Cancer Center) provided updates. Dr. Matthias Kloor (DKFZ) shared progress on Lynch syndrome vaccines, a CAP-IT CRI U54 center Weill Cornell Medicine project.”

Source: CAP-IT/X

cancer Cancer Prevention CAP-IT network clinical trials colorectal cancer DKFZ genetic cancer syndromes hereditary cancer immune response immunotherapy Lynch Syndrome OncoDaily Oncology vaccine development Weill Cornell Medicine

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage